Wołowiec Paweł, Kukołowicz Paweł, Lis Krzysztof
Medical Physics Department, Holycross Cancer Centre, Kielce, Poland.
Medical Physics Department, Holycross Cancer Centre, Kielce, Poland ; The Jan Kochanowski University of Humanities and Sciences, Kielce, Poland.
Rep Pract Oncol Radiother. 2013 Feb 4;18(2):95-100. doi: 10.1016/j.rpor.2012.12.007. eCollection 2013.
To validate a pretreatment verification method of dose calculation and dose delivery based on measurements with Metaplex PTW phantom.
The dose-response relationships for local tumor control and radiosensitive tissue complications are strong. It is widely accepted that an accuracy of dose delivery of about 3.5% (one standard deviation) is required in modern radiotherapy. This goal is difficult to achieve. This paper describes our experience with the control of dose delivery and calculations at the ICRU reference point.
The calculations of dose at the ICRU reference point performed with the treatment planning system CMS XiO were checked by measurements carried out in the PLEXITOM™ phantom. All measurements were performed with the ion chamber positioned in the phantom, at the central axis of the beam, at depth equivalent to the radiological depth (at gantry zero position). The source-to-phantom surface distance was always set to keep the source-to-detector distance equal to the reference point depth defined in the ICRU Report 50 (generally, 100 cm). The dose was measured according to IAEA TRS 398 report for measurements in solid phantoms. The measurement results were corrected with the actual accelerator's output factor and for the non-full scatter conditions. Measurements were made for 111 patients and 327 fields.
The average differences between measurements and calculations were 0.03% (SD = 1.4%), 0.3% (SD = 1.0%), 0.1% (SD = 1.1%), 0.6% (SD = 1.8%), 0.3% (SD = 1.5%) for all measurements, for total dose, for pelvis, thorax and H&N patients, respectively. Only in 15 cases (4.6%), the difference between the measured and the calculated dose was greater than 3%. For these fields, a detailed analysis was undertaken.
The verification method provides an instantaneous verification of dose calculations before the beginning of a patient's treatment. It allows to detect differences smaller than 3.5%.
验证基于Metaplex PTW体模测量的剂量计算和剂量输送的预处理验证方法。
局部肿瘤控制和放射敏感组织并发症的剂量反应关系密切。现代放射治疗中,剂量输送精度约为3.5%(一个标准差)已被广泛接受。但这一目标难以实现。本文描述了我们在ICRU参考点控制剂量输送和计算方面的经验。
使用治疗计划系统CMS XiO在ICRU参考点进行的剂量计算,通过在PLEXITOM™体模中进行的测量来检查。所有测量均在体模中,于射束中心轴、相当于放射学深度的深度(在机架零位)处,将电离室放置于此进行。源到体模表面的距离始终设置为使源到探测器的距离等于ICRU第50号报告中定义的参考点深度(通常为100 cm)。根据国际原子能机构TRS 398报告对固体体模中的测量进行剂量测量。测量结果用实际加速器的输出因子和非完全散射条件进行校正。对111例患者和327个射野进行了测量。
所有测量、总剂量、盆腔、胸部和头颈部患者测量值与计算值的平均差异分别为0.03%(标准差=1.4%)、0.3%(标准差=1.0%)、0.1%(标准差=1.1%)、0.6%(标准差=1.8%)、0.3%(标准差=1.5%)。仅在15例(4.6%)中,测量剂量与计算剂量的差异大于3%。对这些射野进行了详细分析。
该验证方法可在患者治疗开始前对剂量计算进行即时验证。它能够检测出小于3.5%的差异。